Jasper Therapeutics Stock Options

JSPR Stock  USD 23.97  1.16  5.09%   

Jasper Total Stockholder Equity

Total Stockholder Equity

82.36 Million

At this time, Jasper Therapeutics' Total Stockholder Equity is relatively stable compared to the past year.

Jasper Therapeutics Corporate Management

Luca NotoSenior OperationsProfile
Carol ZoltowskiVP QualityProfile
Jeetinder MBAChief OfficerProfile
Wendy MDSenior MedicineProfile

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.